D., Di Michele, L., Laino, G., & Vajro, P
Explain that longterm safety data for offlabel applications is limited, and that ongoing studies aim to clarify these questions
Deterministic and scenario analysis identified treatment duration, time horizon, discount rates, and diabetes-related complication costs as key drivers of ICER variability
The specific medications a patient receives depend entirely on the prescribing provider's independent evaluation
When stored under good conditions, unopened vials can normally last a few years
The FDA says these unapproved compounds do not go through agency review for safety, effectiveness or quality, and it has issued warning letters to companies marketing certain compounded GLP-1 products